The DNM1 Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the DNM1 gene has been disrupted in the A-549 human lung adenocarcinoma cell line. This mixed knockout population provides a loss-of-function model for investigating dynamin-1 function without clonal selection, enabling studies of endocytosis and membrane trafficking in a genetically heterogeneous context that mirrors natural cellular variability.
Host A-549 cells are derived from a human lung adenocarcinoma and serve as a widely used model for type II pulmonary epithelial cells. These adherent epithelial cells retain characteristics of alveolar epithelial cells and are commonly employed in cancer biology, drug uptake, and cellular trafficking studies, making them a relevant platform for probing the role of endocytic machinery in lung cancer.
Dynamin-1, encoded by DNM1, is a large GTPase essential for membrane fission during clathrin-mediated endocytosis. It is activated by upstream signals including calcium influx and calcineurin-mediated dephosphorylation, and it functions downstream of neuronal activity in synaptic vesicle recycling. Dynamin-1 interacts with amphiphysin and endophilin at the necks of budding vesicles, where it collaborates with the AP2 complex and clathrin to promote vesicle scission. The dynamin family includes DNM2 and DNM3, which share overlapping but distinct functions in membrane remodeling.
In the context of A-549 lung carcinoma cells, disruption of DNM1 offers a unique model to dissect the contribution of dynamin-1 to cancer-relevant processes. Dynamin-mediated endocytosis influences receptor internalization, cell migration, and drug sensitivity, and knockout cells allow assessment of how loss of dynamin-1 alters these phenotypes. This model bridges the gap between classical neuronal roles of dynamin-1 and its emerging functions in non-neuronal cells, particularly in the context of tumor cell biology and therapeutic uptake.
Researchers can employ these polyclonal knockout cells in a range of assays including transferrin uptake and EGF internalization studies to quantify clathrin-mediated endocytosis, as well as cell migration and drug sensitivity assays to evaluate functional outcomes. The cells are also suitable for immunofluorescence analysis of clathrin-coated pit morphology and western blotting to confirm dynamin-1 ablation. This knockout population is a valuable tool for studying endocytosis mechanisms, screening endocytosis modulators, and modeling aspects of diseases linked to DNM1 dysfunction, such as developmental epileptic encephalopathy. For additional product information and support, please contact Ascent Research.
